7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Titan Pharmaceuticals, Inc
(NASDAQ:TTNP) 

TTNP stock logo

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company offers Probuphine impla...

Founded: 1992
Full Time Employees: 21
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Titan Pharmaceuticals Days Payable Outstanding ttm (DPO)
202203 202204 202205 202206 202207 202208 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2,657.38-2,003.56-1,349.75-695.93-42.12611.71,265.511,919.33
Titan Pharmaceuticals Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0529.531,059.061,588.592,118.112,647.643,177.173,706.7
Titan Pharmaceuticals Days Inventory Outstanding ttm (DIO)
202203 202204 202205 202206 202207 202208 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -689.94-419.71-149.49120.73390.96661.18931.411,201.63
Titan Pharmaceuticals Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -961.29-823.96-686.64-549.31-411.98-274.65-137.330
Titan Pharmaceuticals Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -961.29-823.96-686.64-549.31-411.98-274.65-137.330
Titan Pharmaceuticals Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 031.2362.4693.7124.93156.16187.39218.62
Titan Pharmaceuticals P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 08.6917.3726.0634.7443.4352.1260.8
Titan Pharmaceuticals (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -18.33-15.71-13.1-10.48-7.86-5.24-2.620
Titan Pharmaceuticals P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -37.15-29.87-22.58-15.3-8.01-0.726.5613.85
No extra charts and metrics for this ticker.